VSBC logo

VitaSpring Biomedical Co. Ltd. Stock Price

OTCPK:VSBC Community·US$51.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VSBC Share Price Performance

US$0.25
0.07 (38.94%)
US$0.25
0.07 (38.94%)
Price US$0.25

VSBC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

VitaSpring Biomedical Co. Ltd. Key Details

-US$1.5m

Revenue

US$2.4m

Cost of Revenue

-US$3.9m

Gross Profit

US$1.1m

Other Expenses

-US$5.0m

Earnings

Last Reported Earnings
Jul 31, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About VSBC

Founded
2016
Employees
n/a
CEO
Ssu-Chuan Lai
WebsiteView website
www.vitaspringbio.com

VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. The company focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. It is also involved in the development of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.

Recent VSBC News & Updates

Recent updates

No updates